BIO-key Emphasizes Nigeria Efforts Amid COVID-19 Pandemic

Amid the ongoing COVID-19 pandemic, BIO-key has issued an update on its activities in Africa, emphasizing its efforts in Nigeria through the company’s local subsidiary.

“Though the African continent, and particularly Nigeria, has been hard-hit by the COVID-19 epidemic, BIO-key’s African subsidiary in Nigeria is maximizing new and existing revenue opportunities while aligning appropriate investments with expected returns,” the company stated.

The biometrics specialist went on to explain that its software and hardware are slated for use in two “externally funded programs” that will require its identity solutions, adding that its partnership with the Technology Transfer Institute remains solid.

The TTI had helped to engineer a $30 million contract to provide biometric authentication solutions for a Nigerian telecom in a deal announced in March. Just a few weeks after that, BIO-key announced a $45 million contract to provide biometric software and hardware solutions for a Nigerian Ministry of Labour program, which involved an affiliate of the TTI.

“We are moving forward as a collaborative partnership, including BIO-key as a named party and provider of technology in our current contracts to deliver secure identity solutions to the Nigerian market,” said TTI Chairwoman Anthea Arnasalam.

Manny Alia, the CEO of TTI and a board member of BIO-key appointed earlier this year, also weighed in. “The opportunity for secure identification including biometrics in Africa remains significant,” he said. “Through our Africa subsidiary, growing partner network and strong balance sheet, we are well-positioned to take advantage of those opportunities across the continent.”

BIO-key said it will continue to provide updates on its efforts in Africa as the work continues.

–

September 8, 2020 – by Alex Perala